Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori

NCT02422706 is registered in ClinicalTrials.gov with Sherief Abd-Elsalam as lead sponsor.

NCT NCT02422706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02422706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori
Lead sponsor
Sherief Abd-Elsalam
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2015
Completion date
December 31, 2018
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter-associated gastritis